A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
Clinical trial NCT05036473 · COMPLETED
Trial details
- NCT number
- NCT05036473
- Sponsor
- Shanghai WD Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-11
- Primary completion
- 2022-12-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.